Evoke Pharma (EVOK) Appoints Greg Pyszczymuka to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. PTC
4. SPY
5. META
6. MSFT
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to Evoke Pharma (EVOK) Appoints Greg Pyszczymuka to its Board

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors

February 24, 2025 8:30 AM EST

SOLANA BEACH, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced the appointment of Greg Pyszczymuka to its Board of Directors, effective February 20, 2025. This marks the second board member appointment by Nantahala Capital Management, reinforcing its continued confidence in Evokes commercial strategy and growth potential.

Mr. Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue growth. He currently serves as Chief... More